This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2009-2014.
Company Filing History:
Years Active: 2009-2014
Title: Jelka Svetek: Innovator in Pharmaceutical Composition
Introduction
Jelka Svetek is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the stabilization of erythropoietin (EPO) compositions. With a total of 2 patents, her work has the potential to impact the medical industry positively.
Latest Patents
Jelka's latest patents include a stable pharmaceutical composition comprising erythropoietin that is stabilized with PVP. This innovative formulation aims to enhance the stability and efficacy of EPO. Additionally, she has developed another stable pharmaceutical composition of erythropoietin that utilizes a combination of a poloxamer polyol and a polyhydric alcohol for stabilization.
Career Highlights
Jelka Svetek is currently employed at Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. Her work at Lek has allowed her to focus on developing advanced pharmaceutical formulations that address critical medical needs.
Collaborations
Jelka has collaborated with notable colleagues, including Tanja Rozman Peterka and Alenka Paris. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jelka Svetek's contributions to pharmaceutical innovation, particularly in the stabilization of erythropoietin, highlight her role as a key inventor in the industry. Her work continues to pave the way for advancements in medical treatments.